Baseline quality of life and chemotherapy toxicities in patients with early breast cancer
Cancer · 2023-04 · 129 (7) · 1085-1095
DOI: 10.1002/cncr.34643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, online erschienen am 15.01.2023. Verfasst von Idlir Licaj und 19 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Department, Centre Francois Baclesse, Caen, France. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
The authors used the French breast cancer Cancer and Toxicities (CANTO) cohort to study the associations between baseline quality of life and chemotherapy dose‐reductions (CDRs) or postchemotherapy‐toxicities (PCTs).
Methods
In total, 3079 patients with breast cancer who received chemotherapy were included in this analysis. The associations between baseline physical functioning (PF) and fatigue measured using the European Organization for Research and Treatment of Cancer Quality‐of‐Life Questionnaire Core 30, and two endpoints—CDRs during adjuvant or neoadjuvant chemotherapy; and selected PCTs were estimated with odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) using logistic regression models.
Results
Among the 3079 patients from the CANTO cohort who were included, 718 (33.0%) received chemotherapy in the neoadjuvant setting, and 2361 (67.0%) received chemotherapy as adjuvant treatment. The chemotherapy included taxanes in 94.2% of patients and anthracyclines in 90.5% of patients. Overall, 15.5% of patients experienced CDRs and, 31.0% developed PCTs. Women with low baseline PF scores (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Research Department, Centre Francois Baclesse, Caen, France.
- Department of Community Medicine, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.
- Medical Oncology, Centre Francois Baclesse, Caen, France.
- Breast and Gynecologic Cancer Registry of Côte d'Or, Georges-François Leclerc Cancer Centre-UNICANCER, Caen, France.
- Supportive Care Department, Gustave Roussy, Villejuif, France.
- Medical Oncology, Gustave Roussy, Villejuif, France.
ORCID-Profile: Idlir Licaj, Tienhan Sandrine Dabakuyo-Yonli, Jerome Lemonnier
Zitieren
APA
Licaj, I., Coquan, E., Dabakuyo-Yonli, T. S., Dauchy, S., Vaz Luis, I., Charles, C., Lemogne, C., Tredan, O., Vanlemmens, L., Jouannaud, C., Levy, C., Rigal, O., Fournier, M., Petit, T., Dalenc, F., Rouanet, P., Lemonnier, J., Everhard, S., Cottu, P., & Joly, F. (2023). Baseline quality of life and chemotherapy toxicities in patients with early breast cancer. Cancer, 129(7), 1085-1095. https://doi.org/10.1002/cncr.34643
Vancouver
Licaj I, Coquan E, Dabakuyo-Yonli TS, Dauchy S, Vaz Luis I, Charles C, et al. Baseline quality of life and chemotherapy toxicities in patients with early breast cancer. Cancer. 2023;129(7):1085-1095. doi:10.1002/cncr.34643
BibTeX
@article{Licaj2023,
author = {Licaj, Idlir and Coquan, Elodie and Dabakuyo-Yonli, Tienhan Sandrine and Dauchy, Sarah and Vaz Luis, Ines and Charles, Cecile and Lemogne, Cedric and Tredan, Olivier and Vanlemmens, Laurence and Jouannaud, Christelle and Levy, Christelle and Rigal, Olivier and Fournier, Marion and Petit, Thierry and Dalenc, Florence and Rouanet, Philippe and Lemonnier, Jerome and Everhard, Sibille and Cottu, Paul and Joly, Florence},
title = {Baseline quality of life and chemotherapy toxicities in patients with early breast cancer},
journal = {Cancer},
year = {2023},
volume = {129},
number = {7},
pages = {1085--1095},
doi = {10.1002/cncr.34643}
}
EUVIMED